MOGN Mgi Pharma (MM)

MGI PHARMA, INC. (Nasdaq:MOGN) today announced that it will present at the BioCentury NewsMakers in the Biotech Industry Investment Conference on Friday, September 9, at 2:20 p.m. Eastern Time. Lonnie Moulder, president and chief executive officer of MGI PHARMA, will give the presentation, which will be webcast live over the Internet. The conference will be held at the Sheraton New York Hotel and Towers in New York City. -0- *T What: MGI PHARMA's presentation at the BioCentury NewsMakers in the Biotech Industry Conference When: Friday, September 9, 2005 at 2:20 p.m. Eastern Time How: Live over the Internet - simply log on to www.mgipharma.com. In addition to the live webcast, the presentation will be archived on the Company's web site for one week. *T About MGI PHARMA MGI PHARMA, INC. is an oncology and acute care focused biopharmaceutical company that acquires, develops and commercializes proprietary products that address the unmet needs of cancer patients. MGI PHARMA markets Aloxi(R) (palonosetron hydrochloride) injection, Kadian(R) (sustained release morphine sulfate) capsules, Salagen(R) Tablets (pilocarpine hydrochloride) and Hexalen(R) (altretamine) capsules in the United States. The company directly markets its products in the U.S. and collaborates with partners to reach international markets. For more information about MGI PHARMA, please visit www.mgipharma.com.